Increased left main coronary artery dimensions in children with sickle cell disease

Arpan R Doshi1, Linda B Pauliks

  • 1Division of Pediatric Cardiology, Department of Pediatric, Penn State Hershey Medical Center, Hershey, PA 17033, USA. arpan.doshi@gmail.com

Pediatric Cardiology
|November 29, 2012
PubMed

Insights

Sickle cell disease (SCD) in children can cause enlarged coronary arteries and left ventricular hypertrophy. Early cardiac screening, including coronary artery assessment, is crucial for pediatric SCD patients.

Area of Science:

  • Pediatric Cardiology
  • Hematology
  • Cardiovascular Research

Background:

  • Cardiac complications are a significant cause of mortality in adults with sickle cell disease (SCD).
  • Cardiac involvement in pediatric SCD patients is less understood compared to adults.
  • Left main coronary artery (LMCA) dimensions and left ventricular mass index (LVMI) are key indicators of cardiac health.

Purpose of the Study:

  • To evaluate the impact of SCD on LMCA dimensions in a contemporary pediatric cohort.
  • To assess left ventricular remodeling, including dilation and hypertrophy, in children with SCD.

Main Methods:

  • Retrospective analysis of echocardiographic data from 68 pediatric SCD patients (2000-2009).
  • Offline measurement of LMCA diameter and calculation of LVMI using sex-specific normal values.
  • Assessment of left ventricular systolic function via fractional shortening.

Main Results:

  • 43% of pediatric SCD patients exhibited enlarged LMCA diameter, with 26% having an LMCA z-score > 3.
  • 34% of patients showed left ventricular dilation (dilated LV), and 24% had LV hypertrophy (LVMI > 50 g/m(2.7)).
  • Elevated LVMI was observed in 60% of boys and 33% of girls, confirming previous findings.

Conclusions:

  • Pediatric SCD patients demonstrate a higher incidence of LMCA dilation and LV hypertrophy.
  • Findings underscore the need for comprehensive cardiac evaluations in children with SCD.
  • Routine assessment of coronary arteries and attention to high coronary z-scores are recommended.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...